Hyperglycemia diverts dividing osteoblastic precursor cells to an adipogenic pathway and induces synthesis of a hyaluronan matrix that is adhesive for monocytes
- PMID: 24569987
- PMCID: PMC4036277
- DOI: 10.1074/jbc.M113.541458
Hyperglycemia diverts dividing osteoblastic precursor cells to an adipogenic pathway and induces synthesis of a hyaluronan matrix that is adhesive for monocytes
Abstract
Isolated rat bone marrow stromal cells cultured in osteogenic medium in which the normal 5.6 mm glucose is changed to hyperglycemic 25.6 mm glucose greatly increase lipid formation between 21-31 days of culture that is associated with decreased biomineralization, up-regulate expression of cyclin D3 and two adipogenic markers (CCAAT/enhancer binding protein α and peroxisome proliferator-activated receptor γ) within 5 days of culture, increase neutral and polar lipid synthesis within 5 days of culture, and form a monocyte-adhesive hyaluronan matrix through an endoplasmic reticulum stress-induced autophagic mechanism. Evidence is also provided that, by 4 weeks after diabetes onset in the streptozotocin-induced diabetic rat model, there is a large loss of trabecular bone mineral density without apparent proportional changes in underlying collagen matrices, a large accumulation of a hyaluronan matrix within the trabecular bone marrow, and adipocytes and macrophages embedded in this hyaluronan matrix. These results support the hypothesis that hyperglycemia in bone marrow diverts dividing osteoblastic precursor cells (bone marrow stromal cells) to a metabolically stressed adipogenic pathway that induces synthesis of a hyaluronan matrix that recruits inflammatory cells and establishes a chronic inflammatory process that demineralizes trabecular cancellous bone.
Keywords: Adipogenesis; Autophagy; Diabetes; ER Stress; Heparin; Inflammation; Monocyte Adhesive Hyaluronan Matrix; Osteogenesis; Osteopenia; Stromal Cell.
Figures
References
-
- Krakauer J. C., McKenna M. J., Buderer N. F., Rao D. S., Whitehouse F. W., Parfitt A. M. (1995) Bone loss and bone turnover in diabetes. Diabetes 44, 775–782 - PubMed
-
- Miazgowski T., Czekalski S. (1998) A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus. Osteoporos. Int. 8, 399–403 - PubMed
-
- Kemink S. A., Hermus A. R., Swinkels L. M., Lutterman J. A., Smals A. G. (2000) Osteopenia in insulin-dependent diabetes mellitus. Prevalence and aspects of pathophysiology. J. Endocrinol. Invest. 23, 295–303 - PubMed
-
- Janghorbani M., Van Dam R. M., Willett W. C., Hu F. B. (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am. J. Epidemiol. 166, 495–505 - PubMed
-
- Verhaeghe J., van Herck E., Visser W. J., Suiker A. M., Thomasset M., Einhorn T. A., Faierman E., Bouillon R. (1990) Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 39, 477–482 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
